Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared on X:
“Brachytherapy boost for high-risk localized rectal cancer.
OPERA ph3 RCT demonstrated improved organ preservation with brachy boost in favorable risk rectal cancer.
Retrospective study shows 3-year organ preservation of 80% for high risk disease.”
Authors: Ngu Wah Than, D. Mark Pritchard, David M. Hughes, Carrie. A. Duckworth, Helen Wong, Muneeb Ul Haq, Rajaram Sripadam, Arthur Sun Myint
